Answers are grounded in this paper and cite their sources.
In Brief Purpose: To describe qualitative and quantitative optical coherence tomography (OCT) angiography (OCTA) parameters for choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) and their applicability as potential clinical trial endpoints. Methods: A review of current literature related to the topic of OCTA and AMD. Results: There are a number of promising OCTA parameters that can be used to diagnose the presence of CNV and to monitor the activity and progression of the lesion, pre- and post-treatment morphological characteristics, CNV dimensions, and automated quantitative parameters such as vessel density. Conclusion: The OCTA parameters described in this review have promise for the future development of clinical trial endpoints, but require further validation before they can be widely used. In this article, the authors present a review of the current literature describing the qualitative and quantitative features of nAMD. These parameters will need to be further validated before they can be consistently used as standardized endpoints.
No takes yet. Share an insight, caveat, or question.
Cole et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: